NCT05351541View on ClinicalTrials.gov

Psilocybin Therapy for Chronic Low Back Pain

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Chronic Low-back Pain
Interventions
DRUG

Psilocybin therapy with Zolpidem and Modafinil

1-30 mg (oral administration), Modafinil (oral administration), and Zolpidem (oral administration)

DRUG

Psilocybin therapy with Zolpidem

1-30 mg (oral administration), Zolpidem (oral administration), and placebo (oral administration)

DRUG

Psilocybin therapy with Modafinil

1-30 mg (oral administration), Modafinil (oral administration), and placebo (oral administration)

DRUG

Psilocybin therapy with Placebo

1-30 mg (oral administration), and placebo (oral administration)

Trial Locations (1)

94107

RECRUITING

University of California San Francisco, San Francisco

All Listed Sponsors
lead

Joshua Woolley, MD, PhD

OTHER